NIH Grants and Funding
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
In this episode of the NIH All About Grants podcast, Deysi Duque, a Senior Clinical Trials Analyst within the NIH Office of Extramural Research, talks us through the clinical trials dissemination policy, its purpose, resources (like this decision tree), exceptions, and what recipient organizations and researchers should know to ensure compliance. This episode builds upon the Open Mike blog from March that discussed NIH’s commitment to “the timely dissemination of clinical trial results information so that the benefits of the trial data can be realized.”
“I can’t stress enough the importance of completing the requirements on time. This is truly a shared commitment to ensure information is disseminated broadly… With help from the research community, we can together provide transparency and accountability of the clinical trials system.” - Deysi Duque
Questions about the clinical trials reporting policy may be sent to OER-HS@NIH.gov. Please also consider listening to our related podcasts on What Researchers and Recipients Should Know About ClinicalTrials.gov, and Basic Experimental Studies with Humans (BESH) (the latter discusses the delayed enforcement for ClinicalTrials.gov registration and results reporting for these types of trials).
